Advertisement
Screener

REGENERON PHARMACEUTICALS, INC. (REGN) Analyst Insights

RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$904.38(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$904.38High(m)Average(m)Low(m)2025-11-062026-11-06
DateStockAnalystFirmPrice When RatedPrice TargetUpside / DownsideRatingPerformance
2026-04-29REGN
REGENERON PHARMACEUTICALS, INC.
Eliana Merle, CFABarclays$686.36$917.00+33.60%Overweight
2026-03-05REGN
REGENERON PHARMACEUTICALS, INC.
Eliana Merle, CFABarclays$787.50$923.00+17.21%Overweight
2024-11-29REGN
REGENERON PHARMACEUTICALS, INC.
Eliana Merle, CFABarclays$754.87Overweight
2024-10-31REGN
REGENERON PHARMACEUTICALS, INC.
Eliana Merle, CFABarclays$838.20$1,065.00+27.06%Overweight
2024-10-23REGN
REGENERON PHARMACEUTICALS, INC.
Eliana Merle, CFABarclays$962.34$1,080.00+12.23%Overweight
2024-08-01REGN
REGENERON PHARMACEUTICALS, INC.
Eliana Merle, CFABarclays$1,079.19$1,220.00+13.05%Overweight
2024-07-10REGN
REGENERON PHARMACEUTICALS, INC.
Eliana Merle, CFABarclays$1,054.03$1,200.00+13.85%Overweight
2024-02-02REGN
REGENERON PHARMACEUTICALS, INC.
Eliana Merle, CFABarclays$957.78$1,050.00+9.63%Overweight
2024-01-22REGN
REGENERON PHARMACEUTICALS, INC.
Eliana Merle, CFABarclays$933.40$1,020.00+9.28%Overweight
2023-11-02REGN
REGENERON PHARMACEUTICALS, INC.
Eliana Merle, CFABarclays$818.79$935.00+14.19%Overweight

Similar stocks

Stock NameCountryMarket CapPE Ratio
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Zoetis Inc. (ZTS)United States$29.045B11.38
INSMED Inc (INSM)United States$26.566B-26.60
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
BRISTOL MYERS SQUIBB CO (BMY)United States$125.637B12.67
Royalty Pharma plc (RPRX)United States$22.628B
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64
Viatris Inc (VTRS)United States$20.008B-0.00
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
Jazz Pharmaceuticals plc (JAZZ)$15.333B16.07